All terms in BAO
| Label | Id | Description |
|---|---|---|
| acrokeratosis verruciformis | DOID_0050606 | |
| differentiating neuroblastoma | DOID_4160 | |
| ganglioneuroblastoma | DOID_4163 | |
| central nervous system mesenchymal non-meningothelial tumor | DOID_502 | |
| ADULT syndrome | DOID_0050601 | [An autosomal dominant disease that is characterized by light pigmentation with excessive freckling, sparse hair involving the scalp and axilla, lacrimal duct stenosis or atresia, onychodysplasia, hypodontia or early loss of permanent teeth, athelia or hypoplastic nipples, and breast hypoplasia, has_material_basis_in a mutation in TP63.] |
| ABCD syndrome | DOID_0050600 | [An autosomal recessive disease that is characterized by albinism, black lock, cell migration disorder of the neurocytes of the gut and sensorineural deafness and has_material_basis_in a mutation in the endothelin B receptor gene (EDNRB).] |
| acheiropody | DOID_0050603 | |
| triple-A syndrome | DOID_0050602 | |
| acrodermatitis enteropathica | DOID_0050605 | |
| signal window | BAO_0000529 | [Difference of signal between positive and negative controls; assay dynamic range: SW={Avg(poscontrol)-Avg(negcontrol)-3x[StdDev(poscontrol)+StdDev(negcontrol)]}/StdDev(poscontrol).] |
| z-prime factor | BAO_0000528 | [It describes the assay dynamic range considering range and data variation: Z'=1-{3x[StdDev(poscontrol)+StdDev(negcontrol)]/[Avg(poscontrol)-Avg(negcontrol)]}] |
| z factor | BAO_0000527 | [It describes the assay dynamic range considering range and data variation: Z=1-{3x[StdDev(sample)+StdDev(negcontrol)]/[Avg(sample)-Avg(negcontrol)]} Not to be confused with z-score.] |
| Escherichia coli | NCBITaxon_562 | |
| biliary papillomatosis | DOID_5468 | [A biliary tract neoplasm characterized by multiple papillary tumors in the intrahepatic and/or extrahepatic biliary tree.] |
| assay comment | BAO_0000525 | [This is the PubChem assay remark that can be assigned by depositors to a bioassay. ] |
| assay depositor | BAO_0000524 | [The role of an organization or individual to add an assay to a repository, such as PubChem.] |
| assay protocol | BAO_0000523 | [This includes the methodology used to perform a particular bioassay and is found on the PubChem website associated with each assay ID (AID). It includes the assay components and the order in which they were added, the incubation times, detection method and the kit used, etc.] |
| assay narrative | BAO_0000522 | [This contains the background information and rationale for performing a bioassay and is found on the PubChem website associated with each assay ID (AID). It also includes the assay design and some information on the related bioassays.] |
| assay title | BAO_0000521 | [The name of a bioassay which is associated with each assay ID (AID). It contains information about the target tested, the stage of the assay (primary or confirmatory), the assay format (biochemical or cell based), etc.] |
| adenosine A2A receptor antagonist | CHEBI_53121 |